1535 related articles for article (PubMed ID: 16942848)
1. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
2. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
3. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Pharm Res; 2006 Sep; 23(9):2200-9. PubMed ID: 16900411
[TBL] [Abstract][Full Text] [Related]
4. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587
[TBL] [Abstract][Full Text] [Related]
5. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
Martin GP; Marriott C; Zeng XM
Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
[TBL] [Abstract][Full Text] [Related]
6. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
Adi H; Larson I; Stewart PJ
Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
[TBL] [Abstract][Full Text] [Related]
7. Entrainment of lactose inhalation powders: a study using laser diffraction.
Watling CP; Elliott JA; Cameron RE
Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
[TBL] [Abstract][Full Text] [Related]
8. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
[TBL] [Abstract][Full Text] [Related]
9. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
[TBL] [Abstract][Full Text] [Related]
10. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
12. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
Kaialy W; Ticehurst M; Nokhodchi A
Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
[TBL] [Abstract][Full Text] [Related]
13. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
[TBL] [Abstract][Full Text] [Related]
14. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
[TBL] [Abstract][Full Text] [Related]
15. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate.
Larhrib H; Zeng XM; Martin GP; Marriott C; Pritchard J
Int J Pharm; 1999 Nov; 191(1):1-14. PubMed ID: 10556735
[TBL] [Abstract][Full Text] [Related]
16. Effect of milling and sieving on functionality of dry powder inhalation products.
Steckel H; Markefka P; teWierik H; Kammelar R
Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction.
Martin GP; MacRitchie HB; Marriott C; Zeng XM
Pharm Res; 2006 Sep; 23(9):2210-9. PubMed ID: 16900410
[TBL] [Abstract][Full Text] [Related]
18. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
20. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
